Kyrgyz State Medical Academy 1

1. A global survey on the attitudes of neurologists and psychiatrists about functional/psychogenic/dissociative/nonepileptic-seizures/attacks, in the search of its name
2. Complementary and alternative medicine in epilepsy: A global survey of physicians’ opinions
3. Counseling about sudden unexpected death in epilepsy (SUDEP): A global survey of neurologists’ opinions
4. Perceived built environment characteristics associated with walking and cycling across 355 communities in 21 countries
5. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
6. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
7. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
8. Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis
9. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
10. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE v survey in 16 European countries
11. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
12. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
13. The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort study
14. FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan
15. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
16. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017
17. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
18. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
19. Diminishing benefits of urban living for children and adolescents’ growth and development
20. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study
21. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
22. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
23. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
24. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
25. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
26. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
27. Asthma control in Kazakhstan: need for urgent action
28. Variability in Decision Making of Breast Cancer Radiologists and Commercial AI Models: Experimental Study
29. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
1